Delivery Order SPE2DB22D1041-SPE2DB25FUAF2
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S, a pharmaceutical product, with a ceiling value of $4,235.30 and a period of performance through May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order (SPE2DB23FRPK7) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,318.60 firm fixed-price contract is for the delivery of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
This federal contract award, valued at $1,575.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 11, 2025. The contract covers the procurement of PRILOSEC DR 2.5 MG SUSPENSION 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PRILOSEC DR 10 MG SUSPENSION 30S. The $2,032.38 firm fixed-price delivery order contract has an ultimate completion date of October 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,149.66 firm fixed price delivery order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a prescription pharmaceutical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Prilosec DR 10 mg Suspension, a prescription medication, with a ceiling value of $10,532.34 and a performance period through July 10, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,808.82, is for the supply of Prilosec DR 10 mg suspension medication. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567908468 - Prilosec DR 10 MG Suspension 30S, a pharmaceutical product. The contract has a ceiling value of $4,039.89 and runs through April 15, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,559.32 firm fixed-price delivery order (SPE2DB22D3004|SPE2DB25FPS06) is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025. It is not designated as a set-aside...